✦ LIBER ✦

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial

✍ Scribed by Hye Jin Kim; Sung-Soo Yoon; Dong Soon Lee; Sang Kyun Sohn; Hyeon Seok Eom; Jung Lim Lee; Joo Seup Chung; Kihyun Kim; Cheolwon Suh; Jong Ho Won; Jin Seok Kim; Joon Seong Park; Hye Jin Kang; Chu Myong Seong; Cheol Soo Kim; Sang Jae Lee; Jae Hoon Lee

Publisher: Springer
Year: 2011
Tongue: English
Weight: 184 KB
Volume: 91
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-011-1298-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A staged approach with vincristine, adri

A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma

✍ C. S. Chim; A. K. W. Lie; E. Y. T. Chan; Y. Y. Leung; S. C. W. Cheung; S. Y. T. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 319 KB

Bortezomib, thalidomide, dexamethasone i

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)

✍ Hyeon-Seok Eom; Yeo-Kyeoung Kim; Joo-Seop Chung; Kihyun Kim; Hyo Jung Kim; Ho Yo 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 153 KB